Scholar Rock price target raised to $25 from $23 at Wedbush

Wedbush raised the firm’s price target on Scholar Rock to $25 from $23 and keeps an Outperform rating on the shares. Ahead of the company’s Phase 3 SAPPHIRE data readout in Q4, the firm reviewed the dataset and setup for the shares. Scholar Rock’s risk/reward is highly favorable at current levels, with limited downside but considerable potential upside, the analyst tells investors in a research note. The firm says that for investors looking ahead to Scholar’s data in obesity, the shares “are still inexpensive” if “holders are willing to ride out the volatility during the quarter.”